您的位置: 首页 > 农业专利 > 详情页

ANTIBODY BINDING TO FIBRONECTIN-EDA FOR PREVENTING MYOCARDIAL INFARCTION-RELATED COMPLICATIONS
专利权人:
发明人:
申请号:
EP11720206.9
公开号:
EP2632950B1
申请日:
2011.05.06
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention is concerned with treatment, prevention, or prevention of progression of myocardial infarction or adverse cardiac remodeling related conditions such as heart failure, aneurysm formation and remote myocardial fibrosis by administering a binding member such as, for example, a neutralizing antibody, binding to fibronectin-EDA, in particular the EDA domain of fibronectin-EDA to a subject in need thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充